By Marcia Lesky
Speakers highlighted key potential applications including diagnosis - from screening to biopsy – as well as intraoperative surgical guidance and the management of disease. This can include treatments for cancer, cardiovascular diseases, diabetes, metabolic disease, wounds/burns and neurodegenerative disease.
But they also clarified the continuing challenges facing researchers, industry and clinicians:
At the end of the meeting, participants agreed there is a need for a globally accessible resource of pooled information, e.g. concerning safety assessments, and resources to help identify information on funding sources, standards and regulations, and academic-industrial partnerships in order to translate technology to clinical use. The team will continue to develop clear recommendations and a path forward that will soon be available on OSA.org.
Posted: 22 September 2015 by Marcia Lesky | with 0 comments
The views expressed by guest contributors to the Discover OSA Blog are not those endorsed by The Optical Society.